Back to Journals » Journal of Healthcare Leadership » Volume 18

Integrating Value Analysis into Healthcare Leadership: A Governance Mechanism for Organizational Decision-Making

Authors Zhang W ORCID logo

Received 8 March 2026

Accepted for publication 29 April 2026

Published 5 May 2026 Volume 2026:18 607808

DOI https://doi.org/10.2147/JHL.S607808

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Dr Pavani Rangachari



Wei Zhang

Doctor of Business Administration Program, College of Business, Westcliff University, Miami, Florida, 33143, USA

Correspondence: Wei Zhang, Email [email protected]

Abstract: Within healthcare systems, leaders increasingly face governance challenges when making complex resource allocation decisions. This conceptual paper reconceptualizes value analysis as a governance mechanism integrated into leadership decision-making. While value analysis traditionally evaluates products and services, it is often treated as a structural component rather than as a governance mechanism embedded within leadership structures. As a result, its role in shaping decision authority and accountability may remain underexamined. Using a conceptual approach informed by governance and leadership perspectives, this paper examines how decision authority, accountability, and cross-functional coordination shape the role and effectiveness of value analysis within organizational decision processes. It suggests that without formal integration into leadership governance, value analysis may function as an advisory exercise rather than an authoritative component of decision-making. The analysis identifies four governance functions through which value analysis may strengthen hospital decision-making: the structuring of decision authority through defined evaluation and approval pathways; the strengthening of accountability through standardized criteria and documentation; the facilitation of cross-functional coordination among clinical, operational, and financial stakeholders; and risk mitigation through structured evaluation prior to major organizational commitments. The effectiveness of value analysis may depend not solely on the presence of review procedures but on how governance design integrates these structural elements into leadership systems. By framing value analysis within leadership governance, this paper clarifies the conditions under which it may become an authoritative element of organizational decision-making rather than merely a technical assessment process. This perspective highlights the importance of leadership engagement and governance design in supporting transparency, consistency, and defensibility in resource allocation decisions.

Keywords: value analysis, healthcare leadership, governance mechanisms, leadership decision-making, organizational governance

Introduction

Healthcare leadership increasingly faces complex governance challenges in resource allocation and organizational decision-making. When value analysis emerged in healthcare, it was tasked with evaluating products, services, and technology. However, these evaluation activities occur within broader resource allocation decisions that ultimately fall under leadership oversight. Value analysis emerged as an internal solution to support evidence-informed decision-making through a structured, evidence-based process. In this study, value analysis is defined as a structured, multidisciplinary evaluation process used in healthcare organizations to assess the clinical, operational, and financial implications of products, services, and technologies prior to resource allocation decisions.1,2 While value analysis is widely applied in practice, it is often conceptualized as a technical or committee-based review process rather than as a governance mechanism embedded within leadership structures. This conceptualization is informed by governance and leadership perspectives, which emphasize the structuring of decision authority, accountability, and coordination within organizational systems. In contrast to adjacent approaches such as value-based healthcare and traditional procurement models, which primarily focus on outcomes measurement or purchasing efficiency, this study positions value analysis as a governance-oriented mechanism that shapes organizational decision-making through structured oversight and leadership integration.

However, value analysis is often treated as a technical or procedural tool rather than as a formal governance mechanism integrated into organizational leadership structures. Prior studies discuss governance structures surrounding value analysis committees and conceptualize value analysis as a committee-based review process, a cost-containment instrument, or a technical assessment tool. Less attention has been given to the governance mechanisms through which decision authority, accountability, and coordination shape its influence within broader decision-making. This omission makes it difficult to recognize how value analysis shapes who holds decision authority and how major organizational commitments are formally approved. Consequently, the structural conditions that determine whether value analysis functions as an authoritative governance instrument remain insufficiently clarified. Without intentional leadership integration, value analysis may function as an advisory exercise rather than a mechanism that meaningfully shapes organizational decisions. Rather than defining value analysis as a standalone evaluative process, this paper conceptualizes value analysis as a leadership-integrated governance mechanism to support structured decision-making within organizational oversight structures. This paper contributes to healthcare leadership scholarships in three primary ways. First, it repositions value analysis from an operational evaluation process to a governance mechanism embedded within leadership systems. Second, it clarifies how decision authority, accountability structures, and cross-functional coordination shape its organizational influence. Third, it specifies the structural conditions under which value analysis transitions from advisory review to an authoritative decision mechanism within leadership governance. This analysis focuses on the governance conditions that determine whether value analysis meaningfully shapes leadership decision-making, moving beyond a purely procedural interpretation. In this view, value analysis functions as part of leadership governance. It influences how authority is exercised, how accountability is structured, and how multidisciplinary coordination is sustained in organizational decision-making. Through a leadership and governance lens, the paper highlights the role of structured governance mechanisms in enhancing consistency, transparency, and accountability within governance processes. In this way, value analysis becomes not simply a review process, but part of how leadership structures and formalizes major decisions.

Conceptual Foundation

This paper adopts a conceptual approach by synthesizing relevant literature from healthcare management, governance, and decision-making research. It aims to develop a governance-oriented framework for understanding value analysis within healthcare leadership structures. It examines value analysis as a structured governance mechanism for organizational decision-making. Nonprofit hospital systems constantly require resource allocation decisions to support daily patient care while maintaining fiscal responsibility. Therefore, value analysis has been widely adopted as an evidence-based approach to evaluating cost, quality, and performance prior to organizational resource allocation decisions.3,4 From the lens of leadership and governance, this paper examines value analysis as a decision-making mechanism integrated into organizational leadership structures and oversight structures rather than as a standalone evaluation process. From a leadership perspective, the effectiveness of value analysis depends more on how decision authority, accountability, and coordination are structured, rather than on the existence of formal review processes.5 By using evidence-based decision-making principles, organizations can enhance the quality and transparency of decision-making processes, thereby supporting decision processes that are objective, accountable, and efficient.6,7

Cost–benefit analysis,8 evidence-based decision-making,9 and value-based purchasing,10 are widely used frameworks in healthcare decision-making and organizational resource allocation research. These theories collectively establish the foundation for examining the mechanisms behind the potential influence of value analysis on cost-effective, evidence-based, rigorous, and accountable organizational decisions. In particular, from a governance perspective, this integration provides an explanation of how value analysis operates as a structured decision-making mechanism rather than a procedural tool. This conceptualization aligns with broader leadership governance scholarship emphasizing the structuring of authority, accountability, and coordination within organizational systems.11 By situating value analysis within these governance dimensions, the framework connects operational evaluation practices to established leadership theories on organizational decision rights and institutional oversight. Based on this integrated framework, this paper examines how structured evaluation practices may strengthen consistency, transparency, and accountability in organizational decision-making.

To operate value analysis within this governance framework, organizational decisions rely on benchmarking as a key data-driven approach.12 Benchmarking is a systematic procedure, and it involves comparing cost, quality, and performance metrics to identify opportunities for improvement across similar clinical products, services, or organizations.13,14 In healthcare organizational decision contexts, benchmarking involves comparing cost and performance data across institutions to inform comparative assessment of pricing and product performance.14,15 Federal regulatory and program guidance further illustrate this point. Quality and performance benchmarks demonstrate how healthcare systems use comparative data to support evaluation and accountability.16 When integrated with value analysis, benchmarking may reinforce evidence-based organizational decision-making. Given this alignment, the integration of benchmarking and value analysis may be understood as a governance-aligned strategy for data-driven and financially sustainable organizational resource allocation in healthcare. The scope of this paper is intentionally centered on organizational resource allocation processes and governance structures in hospital settings.

Governance Mechanisms in Value Analysis

Adopting a governance perspective, the analysis highlights that value analysis may influence hospital decision-making through several interrelated mechanisms. These mechanisms operate not as isolated procedural steps, but as structured governance elements that shape decision authority, accountability, and cross-functional coordination.

First, value analysis may function as a formal mechanism for structuring decision authority. Rather than allowing resource allocation decisions to be driven by individual preference or informal influence, value analysis establishes a defined review pathway: who participates in evaluations, how recommendations are developed, and which criteria govern the approval or rejection. This governance structure may reduce inconsistency in decision processes,1,5 and limit discretionary decision behaviors,17 and inconsistent or unaligned decision actions.18

Second, value analysis may introduce accountability through standardized evaluation criteria and documentation practices. By integrating clinical, operational, and financial reviews into the shared framework, value analysis may create traceability between organizational decisions and priorities. This accountability mechanism may promote consistency in decision-making and enable organizations to justify outcomes based on documented evaluation processes rather than individual preference or informal judgments. This finding aligns with prior studies suggesting that structured governance arrangements and formal review processes contribute to enhanced accountability within hospital decision systems.2,19

Third, value analysis formally may involve clinical leaders, supply chain professionals, and financial stakeholders in the decision-making process. Through cross-functional collaboration and structured decision-making, this coordination mechanism may align diverse perspectives to support collaborative decision-making within a structured governance framework, potentially helping to address coordination gaps between departments and mitigating conflicts that often arise when decisions are made in isolation.

In addition, value analysis may operate as a risk-mitigation mechanism through evidence-based, structured evaluation prior to major organizational commitments.4,20 Through systematic assessment of product performance, operational compatibility, and resource implications (ECRI, 2017),20 value analysis may help reduce the likelihood of acquiring low-performing, redundant, or misaligned products and services. This governance function may provide a basis for justifying decisions, particularly when challenged by budgetary constraints and operational pressures. Collectively, these structural elements position value analysis as more than a technical assessment tool. This analysis suggests that value analysis may serve as a decision-making mechanism that reinforces structure, transparency, and coordination within leadership governance structures. Value analysis, when integrated into organizational governance, may enable organizational decisions to be aligned with both operational requirements and broader organizational accountability. Together, these structural elements constitute the governance conditions that determine whether value analysis may function as an authoritative instrument within leadership governance. To further illustrate these governance relationships, a conceptual framework is summarized in Figure 1, summarizing how value analysis operates as an integrated mechanism within leadership governance structures. The framework identifies four core governance functions: decision authority, accountability, cross-functional coordination, and risk mitigation. These functions collectively shape organizational decision-making by supporting transparency, consistency, and defensibility within resource allocation processes.

A flowchart of value analysis in healthcare leadership governance.

Figure 1 Conceptual Governance Framework of Value Analysis in Healthcare Leadership.

Note. This figure illustrates how value analysis operates as a governance mechanism within healthcare leadership structures.

Leadership and Organizational Governance Implications

The findings of this paper suggest that the effectiveness of value analysis in healthcare decisions may depend on leadership commitment and governance structures. Value analysis is often implemented through formal review steps and evaluation tools. Still, its influence on outcomes may be shaped by how decision authority, accountability, and coordination are embedded within organizational governance. This perspective may reframe value analysis from a technical assessment process to a leadership-enabled decision-making mechanism.

From a leadership standpoint, the findings suggest the importance of clearly defined decision authority within governance structures. When leadership establishes explicit pathways for evaluation, escalation, and approval, value analysis may be recognized as an authoritative mechanism rather than an advisory function.1 This clarity may help constrain informal preferences and vendor-driven pressures when making decisions. In this way, leadership may integrate value analysis within formal decision systems. This perspective aligns with prior research emphasizing the role of governance arrangements in procurement processes.5

Governance mechanisms may also play a critical role in strengthening accountability across decision processes. By grounding organizational decisions in evidence-based evaluation criteria and structured review practices, value analysis may enable organizations to justify outcomes transparently and consistently. This accountability is particularly relevant in nonprofit healthcare organizations, where major decisions are subject to close internal review and external oversight. When governance is carried out effectively, value analysis may provide a defensible framework that aligns actions with organizational priorities.

Cross-functional coordination may be understood as another central governance implication. Major decisions frequently span clinical, operational, and financial domains, each with distinct priorities and risk considerations. The integration of these stakeholders through value analysis committees or structured review forums may support alignment and reduce fragmentation across departments. Leadership plays a pivotal role in sustaining this coordination and ensuring that multidisciplinary input informs final decisions.2,21 This analysis aligns with prior research emphasizing leadership’s role in integrating diverse professional perspectives in healthcare settings.22

The discussion also suggests the role of value analysis as a governance-based risk mitigation mechanism. Structured evaluation prior to commitments may reduce the likelihood of acquiring low-performing, redundant, or misaligned products and services. In situations where constrained budgets and operational pressures exist, this governance function may support more resilient decision practices. Rather than reacting to failures after implementation, value analysis may support proactive risk management through leadership oversight and structured decision-making.

Collectively, these findings contribute to the broader leadership and governance literature by illustrating how value analysis can be institutionalized as a decision-making mechanism within leadership structures. The contribution of this paper lies not in demonstrating specific cost outcomes but in clarifying the governance conditions under which value analysis can meaningfully influence strategic decisions. By emphasizing leadership integration and governance design, this discussion extends existing conceptualizations of value analysis beyond procedural implementation toward organizational decision-making structures. These implications are most directly applicable to hospital-based organizational decision-making contexts and may operate differently in other healthcare settings, such as those with less formalized governance structures or more decentralized decision-making processes.

Future Directions

This paper adopts a conceptual approach and does not aim to provide empirical validation of specific outcomes. Future research may build upon this governance framework by examining how leadership-integrated value analysis operates across different organizational contexts or by exploring its interaction with data-driven decision tools and performance measurement systems. Additionally, future research may further examine how variations in structural governance design influence the extent to which value analysis functions as an authoritative component of leadership decision-making. Comparative analyses across centralized and decentralized governance structures may provide insight into how decision authority is distributed and operationalized. Such work may further contribute to the understanding of how governance design influences leadership effectiveness in healthcare organizations.

Conclusions

In summary, the primary contribution of this paper lies in conceptually clarifying how decision authority, accountability structures, and cross-functional coordination shape the role and effectiveness of value analysis within organizational decision structures. By framing value analysis within leadership governance, this paper suggests the conditions under which it may move beyond advisory review and become part of authoritative decision-making. This paper may reframe value analysis as a leadership-enabled governance mechanism within healthcare decision processes rather than as a standalone technical or evaluative tool. Through a leadership and governance lens, value analysis, as a governance mechanism, may shape the effectiveness of organizational decision-making. The analysis suggests that value analysis may exert a meaningful influence on organizational outcomes not through procedural rigor alone, but through its integration into organizational governance structures.

The clarification of the governance conditions suggests how value analysis can function as an authoritative decision-making mechanism. When integrated within leadership structures and supported by clear governance design, value analysis may enhance transparency, consistency, and defensibility in major decisions. This perspective is particularly relevant for nonprofit healthcare organizations operating under fiscal constraints and heightened accountability expectations, where major decisions must balance operational efficiency with responsible stewardship.

From a practical standpoint, the conclusions suggest the importance of leadership engagement in structuring value analysis processes. Healthcare leaders may strengthen governance by formalizing decision pathways, reinforcing multidisciplinary coordination, and aligning evaluation criteria with organizational priorities. These governance practices may enable value analysis to move beyond advisory review and contribute more directly to strategic decision-making. This study provides a conceptual foundation for future empirical and applied research to further examine how governance design shapes the role and impact of value analysis in healthcare organizations.

Acknowledgments

The author reports no funding and no institutional support for this research.

Disclosure

The author declares no conflicts of interest related to this study.

References

1. Engelman DT, Boyle EM, Benjamin EM. Addressing the imperative to evolve the hospital new product value analysis process. J Thorac Cardiovasc Surg. 2017;155(2):682–6. doi:10.1016/j.jtcvs.2017.10.057

2. Kalainov DM. Value-based healthcare: controlling costs through a value analysis committee. Clin Orthop Relat Res. 2024;482(5):769–771. doi:10.1097/corr.0000000000003039

3. Rahmani K, Karimi S, Rezayatmand R, Raeisi AR. Value-Based procurement for medical devices: a scoping review. Med J Islamic Republic Iran. 2021;35:134. doi:10.47176/mjiri.35.134

4. American Hospital Value Analysis Professionals; ECRI. Evolution of Risk Mitigation in Value Analysis During the COVID-19 Pandemic. 2021. Available from: https://ahvap.memberclicks.net/assets/docs/AHVAP-ECRI_Whitepaper_RiskMi.pdf. Accessed March 3, 2026.

5. Hinrichs-Krapels S, Ditewig B, Boulding H, Chalkidou A, Erskine J, Shokraneh F. Purchasing high-cost medical devices and equipment in hospitals: a systematic review. BMJ Open. 2022;12(9):e057516. doi:10.1136/bmjopen-2021-057516

6. World Health Organization. Evidence-informed decision-making for health system governance: a who guidance. World Health Organization; 2022. Available from: https://www.who.int/publications/i/item/9789240039872. Accessed March 3, 2026.

7. Pan American Health Organization. A guide for evidence-informed decision-making, including in health emergencies. Pan American Health Organization; 2022. Available from: https://iris.paho.org/handle/10665.2/55886. Accessed March 3, 2026.

8. Drèze J, Stern N. Chapter 14 The theory of cost-benefit analysis. Handbook of Public Economics. 1987:909–989. doi:10.1016/s1573-4420(87)80009-5

9. Sackett DL, Rosenberg WMC, a M GJ, Haynes RB, Richardson WS. Evidence based medicine: what it is and what it isn’t. BMJ. 1996;312(7023):71–72. doi:10.1136/bmj.312.7023.71

10. Teisberg E, Wallace S, O’Hara S. Defining and implementing value-based health care: a strategic framework. Acad Med. 2019;95(5):682–685. doi:10.1097/acm.0000000000003122

11. Ansell C, Gash A. Collaborative governance in theory and practice. J. Public Adm. Res. Theory. 2007;18(4):543–571. doi:10.1093/jopart/mum032

12. Naranjo-Gil D, Ruiz-Muñoz D. Aplicación del benchmarking en la gestión de la cadena de aprovisionamiento sanitaria: efectos sobre el coste y la calidad de las compras. Gaceta Sanitaria. 2014;29(2):118–122. doi:10.1016/j.gaceta.2014.11.003

13. Camp RC. Benchmarking: the search for industry best practices that lead to superior performance. Productivity. 1989. doi:10.4324/9781003578871

14. Ettorchi-Tardy A, Levif M, Michel P. Comité de coordination de l’évaluation clinique et de la qualité en Aquitaine (CCECQA), EA 495 Laboratoire d’analyse des problèmes sociaux et de l’action collective (LAPSAC), Université Bordeaux Segalen. Benchmarking: a Method for Continuous Quality Improvement in Health. Healthcare policy = Politiques de sante. 2012;7:e101–19.

15. OECD. Health at a Glance 2023: OECD Indicators. Paris: OECD Publishing; 2023. doi:10.1787/7a7afb35-en

16. Centers for Medicare & Medicaid Services. Merit-Based Incentive Payment System (MIPS) Quality Measure Benchmarks Overview; 2023.

17. Burns LR, Lee JA. Hospital purchasing alliances. Health Care Manag. Rev. 2008;33(3):203–215. doi:10.1097/01.hmr.0000324906.04025.33

18. Pedroso CB, Schneller E, Rebolledo C, Beaulieu M. Translating strategies into tactical actions: the role of sourcing levers in healthcare procurement. Hospitals. 2025;2(2):12. doi:10.3390/hospitals2020012

19. Jalilvand MA, Raeisi AR, Shaarbafchizadeh N. Hospital governance accountability structure: a scoping review. BMC Health Serv Res. 2024;24(1):47. doi:10.1186/s12913-023-10135-0

20. ECRI, 2017 ECRI Institute. Value ANALYSIS BEST PRACTICES FOR NAVIGATING THE EVIDENCE Maze.; 2017. Available from: https://www.ecri.org/Resources/Whitepapers_and_reports/Value_Analysis/2017_Value_Analysis_Evidence_Maze.pdf. Accessed April 30, 2026.

21. Carstensen K, Kjeldsen AM, Nielsen CP. Distributed leadership in health quality improvement collaboratives. Health Care Manag. Rev. 2023;49(1):46–58. doi:10.1097/hmr.0000000000000385

22. Tataw DB, Stokes EW. Leadership in interProfessional healthcare practice (IPHP): readiness, roles, and compentencies for healthcare managers and human resource professionals. J Interprof Educ Pract. 2023;32:100635. doi:10.1016/j.xjep.2023.100635

Creative Commons License © 2026 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms and incorporate the Creative Commons Attribution - Non Commercial (unported, 4.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.